- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Amazon.com (AMZN) Trades at Significant Discount to Intrinsic Value | ||
| Mo | Alphabet's (GOOG) Sustainable Growth Outlook Appears Stronger Than Expectations | ||
| Mo | Arm Holdings (ARM) Shifts Strategy to Sell Own Data Center Chips | ||
| Mo | Hackers Breach Apollo Global (APO) Right as Assets Hit $1 Trillion | ||
| Mo | Evaluating RELX PLC's (RELX) Enterprise Advantages in the AI Era | ||
| Mo | InterContinental Hotels Group (IHG): AI Search Functions Improve Visibility and Customer Reach | ||
| Mo | AbbVie's Humira Replacement Strategy Is Working, But Could Growth Be Too Concentrated? | ||
| Mo | Pfizer vs. Johnson & Johnson: Which Pharma Giant Is Better Prepared for Its Patent Cliff? | ||
| Mo | Zoetis Wins Emergency Authorization for Simparica Trio, Can It Support a Slowing U.S. Business? | ||
| Mo | Gilead's Core Business Is Accelerating, But Will Its $11 Billion Pipeline Bet Pay Off? | ||
| Mo | AstraZeneca's Earnings Beat Shows Momentum, But Can its Pipeline Deliver $80 Billion in Revenue? | ||
| Mo | Novo Nordisk Expands Its AI Push With AWS, But Can It Accelerate Drug Discovery? | ||
| Mo | Disney Adds Formula E to Disney+: Can Live Sports Strengthen its Streaming Business? | ||
| Mo | Abbott vs. Intuitive Surgical: Which MedTech Stock Offers Better Long-Term Upside? | ||
| Mo | Gilead's HIV Business is Surging, but is the Company Too Dependent on One Franchise? | ||
| Mo | Pfizer's Turnaround is Gaining Traction, but Can New Products Offset its Patent Cliff? | ||
| Mo | Medtronic vs. Thermo Fisher: Which Healthcare Turnaround Offers More Upside? | ||
| Mo | Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery? | ||
| Mo | Johnson & Johnson vs. Thermo Fisher: Which Healthcare Growth Story Is More Durable? | ||
| Mo | Danaher vs. Intuitive Surgical: Is Recovery or Innovation the Better Long-Term Bet? | ||
| So | Gilead's Revenue Is Accelerating, But are its Acquisitions Worth the Cost? | ||
| So | Pfizer vs. Gilead: Which Drugmaker Has the Stronger Growth Story? | ||
| So | Zoetis Earnings Reveal a Divided Business, But Can its Pipeline Restore Growth? | ||
| So | Medtronic vs. Tenet Healthcare: Which Healthcare Stock Offers Better Long-Term Growth? | ||
| So | Marvell's $120 Billion Google Number: How Much of It Is Real? |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.